Clinical Trials on Diopathic Pulmonary Fibrosis in South Africa
Total 1212 results
-
InSilico Medicine Hong Kong LimitedRecruitingIdiopathic Pulmonary Fibrosis (IPF)United States
-
Genentech, Inc.Hoffmann-La RocheCompletedIdiopathic Pulmonary FibrosisUnited States
-
siRNAgen Therapeutics Inc.Active, not recruiting
-
Endeavor Biomedicines, Inc.CompletedIdiopathic Pulmonary FibrosisAustralia
-
Endeavor Biomedicines, Inc.Not yet recruitingIdiopathic Pulmonary Fibrosis | Progressive Fibrosing Interstitial Lung Disease | Progressive Pulmonary FibrosisUnited States, Switzerland, Canada, Australia, Austria, United Kingdom, Malaysia, Mexico, Germany, Ireland, Korea, Republic of
-
FibroGenCompletedIdiopathic Pulmonary FibrosisUnited States, New Zealand, India, South Africa, Australia, Bulgaria, Canada
-
Biosplice Therapeutics, Inc.WithdrawnIdiopathic Pulmonary FibrosisAustralia, New Zealand
-
Galecto Biotech ABSyneos Health; bioRASI, LLCCompletedIdiopathic Pulmonary Fibrosis (IPF)United States, Spain, Israel, France, United Kingdom, Russian Federation, Australia, Italy, Germany, Canada, Belgium, Georgia, Ireland, Poland, Ukraine
-
Duke UniversityBoehringer IngelheimRecruitingIdiopathic Pulmonary Fibrosis, Interstitial Lung DiseaseUnited States, Puerto Rico
-
Gilead SciencesTerminatedIdiopathic Pulmonary FibrosisUnited States
-
Algernon PharmaceuticalsCompletedIdiopathic Pulmonary FibrosisAustralia, New Zealand
-
Gilead SciencesCompletedIdiopathic Pulmonary FibrosisUnited States
-
Boehringer IngelheimApproved for marketingIdiopathic Pulmonary FibrosisUnited States
-
ActelionCompletedIdiopathic Pulmonary FibrosisUnited States, Israel, Spain, Australia, France, Canada, Turkey, Germany, Italy, South Africa, Slovenia, Sweden
-
Boehringer IngelheimCompletedPulmonary FibrosisArgentina, Australia, Belgium, Brazil, Bulgaria, Canada, Chile, China, Czech Republic, France, Germany, Greece, Hungary, Ireland, Italy, Korea, Republic of, Mexico, Netherlands, Portugal, Russian Federation, South Africa, Spain, Taiwan and more
-
University of Alabama at BirminghamNational Institutes of Health (NIH)CompletedAmbulatory IPFUnited States
-
Kadmon Corporation, LLCCompletedIdiopathic Pulmonary FibrosisUnited States
-
ImmuneWorksCompletedIdiopathic Pulmonary FibrosisUnited States
-
Galapagos NVTerminatedIdiopathic Pulmonary FibrosisUnited States, Netherlands, Korea, Republic of, Israel, Japan, New Zealand, France, Italy, Argentina, Germany, Hungary, South Africa, Poland, Canada, Mexico
-
Pulmonary Fibrosis FoundationUniversity of MichiganCompletedInterstitial Lung Disease (ILD) | Idiopathic Pulmonary Fibrosis (IPF)United States
-
SanofiCompletedIdiopathic Pulmonary FibrosisSpain, United States, Canada, Chile, Mexico
-
Toray Industries, IncCompletedIdiopathic Pulmonary FibrosisUnited States
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisCanada, United States, Netherlands, France, Italy, Germany
-
Hoffmann-La RocheCompletedIdiopathic Pulmonary FibrosisHungary, Belgium, Germany, Netherlands, Italy, Israel, Spain, Canada, South Africa, Turkey, Czechia, Egypt, Greece
-
CelgeneTerminatedPathologic Processes | Fibrosis | Respiratory Tract Diseases | Lung Diseases | Idiopathic Pulmonary Fibrosis | Lung Diseases, Interstitial | Idiopathic Interstitial PneumoniasUnited States, Australia, Colombia, United Kingdom, Russian Federation, Brazil, Germany, Canada, Greece, Romania, Taiwan, Turkey, Ukraine
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisUnited States, Canada, Turkey
-
MedImmune LLCTerminatedIdiopathic Pulmonary FibrosisUnited States, Australia, Korea, Republic of, Peru, Canada, Israel
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisUnited States, Spain, Korea, Republic of, Canada, Belgium, Australia, United Kingdom, Germany, Italy, France, Japan, Mexico, India
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI); Duke Clinical Research InstituteTerminatedIdiopathic Pulmonary FibrosisUnited States
-
AmgenActive, not recruitingIdiopathic Pulmonary FibrosisUnited States, Spain, Korea, Republic of, Australia, Japan, Canada, Taiwan, Netherlands, Italy, Chile, Greece, Mexico, Germany, France, Argentina, Poland, Turkey, South Africa, United Kingdom
-
ActelionCompletedIdiopathic Pulmonary FibrosisUnited States, France, Spain, Korea, Republic of, Canada, United Kingdom, Australia, Belgium, Netherlands, Japan, Germany, Czech Republic, Italy, Switzerland, Austria, Croatia, Ireland, Israel, Serbia
-
Bristol-Myers SquibbCompletedIdiopathic Pulmonary FibrosisUnited States, Mexico, Australia, Colombia, Chile, Peru
-
Centocor, Inc.CompletedPulmonary FibrosisUnited States, Canada, Netherlands, Belgium, Germany
-
Bridge Biotherapeutics, Inc.RecruitingIdiopathic Pulmonary FibrosisUnited States, Korea, Republic of, Australia, Israel, Poland
-
Gilead SciencesTerminatedIdiopathic Pulmonary FibrosisBelgium, France, Germany, Israel, Spain, United States, Switzerland, Colombia, Mexico, Italy, Czech Republic, Australia, Canada, Austria, Poland, United Kingdom, Argentina, Netherlands, Peru, Ireland, Brazil, Chile
-
Pliant Therapeutics, Inc.RecruitingIdiopathic Pulmonary FibrosisUnited States, Australia, Taiwan, Korea, Republic of, Portugal, Germany, Israel, Denmark, New Zealand, Netherlands, Canada, Chile, Czechia, France, Greece, Italy, Poland
-
BiogenTerminatedIdiopathic Pulmonary FibrosisUnited States, Italy, Belgium, Czechia, Russian Federation, Korea, Republic of, Australia, France, Israel, Spain, Poland, Netherlands, Denmark, Greece, Argentina, Chile, United Kingdom
-
Boehringer IngelheimCompletedPulmonary FibrosisUnited States, Canada, Chile, China, Finland, France, Germany, Greece, India, Japan, Korea, Republic of, Mexico, Netherlands, Portugal, Russian Federation, Spain, Turkey
-
Hoffmann-La RocheCompletedIdiopathic Pulmonary FibrosisUnited States, Canada, Denmark, France, Germany, Italy, Netherlands, Spain
-
Tvardi Therapeutics, IncorporatedRecruitingIdiopathic Pulmonary FibrosisUnited States
-
Endeavor Biomedicines, Inc.CompletedIdiopathic Pulmonary FibrosisCanada, Malaysia, Australia, Mexico, Korea, Republic of
-
Daewoong Pharmaceutical Co. LTD.RecruitingIdiopathic Pulmonary FibrosisUnited States, Korea, Republic of
-
Gilead SciencesTerminatedIdiopathic Pulmonary FibrosisUnited States, Spain, Korea, Republic of, Israel, Australia, Italy, Canada, United Kingdom, Switzerland, Germany, Poland, Czechia, Belgium, France
-
PureTechActive, not recruitingIdiopathic Pulmonary FibrosisThailand, United States, Korea, Republic of, Philippines, Greece, Georgia, Malaysia, Mexico, Chile, Argentina, Colombia, India, South Africa, Romania
-
Boehringer IngelheimCompletedPulmonary FibrosisUnited States, Australia, Belgium, China, Czech Republic, France, Germany, India, Ireland, Israel, Italy, Japan, United Kingdom
-
Novartis PharmaceuticalsActive, not recruitingIdiopathic Pulmonary FibrosisPoland, Germany, United States, Australia, Czechia, Argentina, Netherlands
-
Pliant Therapeutics, Inc.CompletedIdiopathic Pulmonary FibrosisUnited States, Belgium, Australia, Netherlands, Canada, Italy, New Zealand
-
Hoffmann-La RocheCompletedIdiopathic Pulmonary FibrosisUnited States, Belgium, Germany, Peru, Mexico, Poland, France, Italy, United Kingdom, Australia, Canada, Spain, Japan
-
ActelionCompletedIdiopathic Pulmonary FibrosisUnited States, France, Spain, Korea, Republic of, United Kingdom, Belgium, Japan, Australia, Canada, Czech Republic, Germany, Ireland, Israel, Italy, Switzerland
-
Boehringer IngelheimCompletedPulmonary FibrosisSpain, Belgium, Canada, Germany, China, United Kingdom, Australia, Ireland, Italy, Mexico, Netherlands, Portugal, Argentina, France, Russian Federation, Greece, Czechia, Brazil, Bulgaria, Chile, Hungary